BioSpace News Archive

Myeloproliferative disorders are a group of blood cancers characterized by the abrupt growth of abnormal white blood cells, platelets, or red blood cells.

The global animal blood plasma products and derivatives market is has a fragmented vendor landscape due to the presence of several players, Transparency Market Research observes.

Traditional drug delivery methods like capsules, pills, liquids, intravenous needles and powders are often ineffective and may result in undesirable side effects.

The chlamydia infection diagnostics and therapeutics market unveils high potential owing to the rapidly rising patient pool and vast untapped opportunities, especially in developing economies across regions such as Asia Pacific and Latin America.

TMR observes that the global transdermal scopolamine market is experiencing the high competition and consolidation due to presence of strong players.

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, and The University of Texas MD Anderson Cancer Center today announced a strategic research collaboration and commercialization agreement to develop novel CD3 bispecific antibody therapeutics for the potential treatment of patients with cancer.

DermTech, Inc., a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced that it has commenced a proposed underwritten public offering of its common stock.

Senseonics Holdings, Inc., a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring system for people with diabetes, announced that it had made equity grants to new employees under its 2019 Inducement Plan in accordance with NYSE American Company Guide Section 711.

Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that management will participate in a fireside chat presentation at the H.C. Wainwright BioConnect 2021 Conference, being held virtually January 11-14, 2021 .

SmileDirectClub, Inc., the oral care company with the first medtech platform for teeth straightening, announced that management will present at the upcoming 39th Annual J.P. Morgan Healthcare Conference, held virtually, on Wednesday, January 13, 2021 at 11:40 a.m. ET.